APA (7th ed.) Citation

G, W., MP, G., A, G., K, E., KA, E., LD, F., & JM, D. (2022). A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19. Critical care (London, England), 26(1), 229. https://doi.org/10.1186/s13054-022-04096-9

Chicago Style (17th ed.) Citation

G, Wagener, Goldklang MP, Gerber A, Elisman K, Eiseman KA, Fonseca LD, and D'Armiento JM. "A Randomized, Placebo-controlled, Double-blinded Pilot Study of Angiotensin 1-7 (TXA-127) for the Treatment of Severe COVID-19." Critical Care (London, England) 26, no. 1 (2022): 229. https://doi.org/10.1186/s13054-022-04096-9.

MLA (9th ed.) Citation

G, Wagener, et al. "A Randomized, Placebo-controlled, Double-blinded Pilot Study of Angiotensin 1-7 (TXA-127) for the Treatment of Severe COVID-19." Critical Care (London, England), vol. 26, no. 1, 2022, p. 229, https://doi.org/10.1186/s13054-022-04096-9.